Endothelial lipase
The LIPG gene encodes a lipase which is involved in intravascular lipolysis. Therefore it is a probably candidate for mutation in hypertriglyceridemia.
Genetests:
| Clinic | Method | Carrier testing |
| Turnaround | 5 days | |
| Specimen type | genomic DNA |
| Research | Method | Genomic sequencing of the entire coding region |
| Turnaround | 25 days | |
| Specimen type | genomic DNA |
| Clinic | Method | Massive parallel sequencing |
| Turnaround | 25 days | |
| Specimen type | genomic DNA |
Related Diseases:
Combined familial hyperlipidemia with dysfunctional VLDL metabolism
|
|||
|
ANGPTL8
|
||
|
|
APOA1
|
||
|
|
APOA4
|
||
|
|
APOA5
|
||
|
|
APOC3
|
||
|
|
CETP
|
||
|
|
GALNT2
|
||
|
|
LCAT
|
||
|
|
LIPC
|
||
|
|
LIPG
|
||
|
|
LPL
|
||
|
|
RXRG
|
||
|
USF1
|
||
|
|
|
|
References:
| 1. |
Cefalù AB et. al. () Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing. [^] |
| 2. |
Jaye M et. al. (1999) A novel endothelial-derived lipase that modulates HDL metabolism. [^] |
| 3. |
Hirata K et. al. (1999) Cloning of a unique lipase from endothelial cells extends the lipase gene family. [^] |
| 4. |
Ishida T et. al. (2003) Endothelial lipase is a major determinant of HDL level. [^] |
| 5. |
Jin W et. al. (2003) Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. [^] |
| 6. |
Yamakawa-Kobayashi K et. al. (2003) Relationship between serum HDL-C levels and common genetic variants of the endothelial lipase gene in Japanese school-aged children. [^] |
| 7. |
Ishida T et. al. (2004) Molecular cloning of nonsecreted endothelial cell-derived lipase isoforms. [^] |
| 8. |
Ishida T et. al. (2004) Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. [^] |
